Kanwal Khan

534 total citations
36 papers, 352 citations indexed

About

Kanwal Khan is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Kanwal Khan has authored 36 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 12 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Kanwal Khan's work include vaccines and immunoinformatics approaches (15 papers), Bacteriophages and microbial interactions (6 papers) and Computational Drug Discovery Methods (6 papers). Kanwal Khan is often cited by papers focused on vaccines and immunoinformatics approaches (15 papers), Bacteriophages and microbial interactions (6 papers) and Computational Drug Discovery Methods (6 papers). Kanwal Khan collaborates with scholars based in Pakistan, Saudi Arabia and China. Kanwal Khan's co-authors include Khurshid Jalal, Reaz Uddin, Muhammad Abbas, Zarrin Basharat, Saeed Ahmad Khan, Ghallab Alotaibi, Zaheer Ul‐Haq, Muhammad Umar Khayam Sahibzada, Saud Bawazeer and Tareq Abu‐Izneid and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Kanwal Khan

36 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kanwal Khan Pakistan 13 244 92 51 44 43 36 352
Khurshid Jalal Pakistan 12 235 1.0× 92 1.0× 48 0.9× 42 1.0× 43 1.0× 34 336
Darío Fernández Do Porto Argentina 10 204 0.8× 60 0.7× 50 1.0× 53 1.2× 13 0.3× 37 351
Muhammad Shehroz Pakistan 13 347 1.4× 112 1.2× 104 2.0× 67 1.5× 88 2.0× 29 484
Meagan Hamblin United States 7 317 1.3× 106 1.2× 54 1.1× 40 0.9× 13 0.3× 11 583
Jude Nnaemeka Okoyeh Nigeria 8 185 0.8× 63 0.7× 74 1.5× 23 0.5× 37 0.9× 20 454
Débora de Oliveira Lopes Brazil 12 283 1.2× 72 0.8× 85 1.7× 60 1.4× 80 1.9× 39 473
Shakhinur Islam Mondal Bangladesh 12 207 0.8× 121 1.3× 35 0.7× 108 2.5× 13 0.3× 25 455
Mohammad Uzzal Hossain Bangladesh 12 279 1.1× 126 1.4× 78 1.5× 32 0.7× 48 1.1× 48 433
Sameeh M. Salama Canada 9 145 0.6× 83 0.9× 76 1.5× 48 1.1× 19 0.4× 11 404
Ezequiel Sosa Argentina 9 150 0.6× 59 0.6× 49 1.0× 34 0.8× 8 0.2× 23 252

Countries citing papers authored by Kanwal Khan

Since Specialization
Citations

This map shows the geographic impact of Kanwal Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanwal Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanwal Khan more than expected).

Fields of papers citing papers by Kanwal Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanwal Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanwal Khan. The network helps show where Kanwal Khan may publish in the future.

Co-authorship network of co-authors of Kanwal Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Kanwal Khan. A scholar is included among the top collaborators of Kanwal Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanwal Khan. Kanwal Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Kanwal, et al.. (2024). Lysine metabolism pathway as a target for drug repurposing: In silico approach against carbapenem-resistant Klebsiella pneumoniae. Gene Reports. 37. 102028–102028. 2 indexed citations
3.
Khan, Kanwal, Khurshid Jalal, Urooj Haroon, et al.. (2024). Identification of therapeutic drug target of Shigella Flexneri serotype X through subtractive genomic approach and in-silico screening based on drug repurposing. Infection Genetics and Evolution. 122. 105611–105611. 1 indexed citations
4.
Khan, Kanwal, et al.. (2023). Lead identification against Mycobacterium tuberculosis using highly enriched active molecules against pantothenate synthetase. Journal of Biomolecular Structure and Dynamics. 42(20). 11080–11097. 2 indexed citations
7.
Khan, Kanwal, et al.. (2023). The Gene Network Correlation Analysis of Obesity to Type 1 Diabetes and Cardiovascular Disorders: An Interactome-Based Bioinformatics Approach. Molecular Biotechnology. 66(8). 2123–2143. 1 indexed citations
8.
Khan, Kanwal, Khurshid Jalal, & Reaz Uddin. (2023). Pangenome diversification and resistance gene characterization in Salmonella Typhi prioritized RfaJ as a significant therapeutic marker. Journal of Genetic Engineering and Biotechnology. 21(1). 125–125. 4 indexed citations
9.
Khan, Kanwal, Khurshid Jalal, Ghallab Alotaibi, et al.. (2023). An integrated computational approach to infer therapeutic targets from Campylobacter concisus and peptidomimetic based inhibition of its pyrimidine metabolism pathway. Journal of Biomolecular Structure and Dynamics. 41(22). 13127–13137. 1 indexed citations
10.
Khan, Kanwal, Muhammad Abbas, Syed Qamar Abbas, et al.. (2022). Integrated Bioinformatics-Based Subtractive Genomics Approach to Decipher the Therapeutic Drug Target and Its Possible Intervention against Brucellosis. Bioengineering. 9(11). 633–633. 14 indexed citations
11.
Khan, Kanwal, Zarrin Basharat, Khurshid Jalal, et al.. (2022). Identification of Therapeutic Targets in an Emerging Gastrointestinal Pathogen Campylobacter ureolyticus and Possible Intervention through Natural Products. Antibiotics. 11(5). 680–680. 6 indexed citations
12.
Alturki, Norah A., Mutaib M. Mashraqi, Khurshid Jalal, et al.. (2022). Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated Fusobacterium nucleatum. Cancers. 14(24). 6260–6260. 11 indexed citations
13.
Khan, Kanwal, Khurshid Jalal, Ajmal Khan, Ahmed Al-Harrasi, & Reaz Uddin. (2022). Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against Streptococcus pneumoniae. Frontiers in Microbiology. 12. 796363–796363. 21 indexed citations
14.
Jalal, Khurshid, Kanwal Khan, Zarrin Basharat, et al.. (2022). Reverse vaccinology approach for multi-epitope centered vaccine design against delta variant of the SARS-CoV-2. Environmental Science and Pollution Research. 29(40). 60035–60053. 27 indexed citations
15.
Jalal, Khurshid, Kanwal Khan, & Reaz Uddin. (2022). Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300. Immunologic Research. 71(2). 247–266. 17 indexed citations
16.
Khan, Kanwal, et al.. (2022). Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro. Computers in Biology and Medicine. 151(Pt A). 106284–106284. 4 indexed citations
17.
Khan, Kanwal, et al.. (2022). Subtractive genomics profiling for potential drug targets identification against Moraxella catarrhalis. PLoS ONE. 17(8). e0273252–e0273252. 18 indexed citations
19.
Jalal, Khurshid, Tareq Abu‐Izneid, Kanwal Khan, et al.. (2022). Identification of vaccine and drug targets in Shigella dysenteriae sd197 using reverse vaccinology approach. Scientific Reports. 12(1). 251–251. 35 indexed citations
20.
Basharat, Zarrin, Kanwal Khan, Ghallab Alotaibi, et al.. (2021). Differential analysis of Orientia tsutsugamushi genomes for therapeutic target identification and possible intervention through natural product inhibitor screening. Computers in Biology and Medicine. 141. 105165–105165. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026